When does xarelto lose patent in switzerland?

When does Xarelto lose patent protection in Switzerland?

Xarelto (rivaroxaban) is covered by multiple layers of intellectual property (not a single “one-and-done” patent date). In practice, the date people mean when they ask about “losing patent” is usually the end of the relevant Swiss patent term for the key formulation/compound protection, and sometimes later extensions or additional patents tied to specific uses.

DrugPatentWatch.com tracks patent and market-exclusivity timelines by country. You can check the Switzerland schedule for Xarelto there to see the specific “patent expiry” dates that apply in Switzerland: DrugPatentWatch.com – Xarelto (rivaroxaban) patent expiry Switzerland.

Does the “end of patent” happen the same day as “generic entry” in Switzerland?

Not always. Even after the main patent expiry, delays can occur from other still-active patents or data/exclusivity periods covering aspects such as the formulation, dosing, or specific regulatory protections. That’s why it helps to look at the full list of active patents in Switzerland rather than one date.

What if I mean “exclusivity” instead of “patent”?

Users often use “patent” loosely to mean market exclusivity. DrugPatentWatch.com distinguishes different IP and exclusivity elements when data is available, so the Switzerland view is the right place to confirm whether you’re looking at:
- patent term expiry, and/or
- other exclusivity barriers that can still prevent generics or biosimilars.

How to confirm the exact Swiss date for your planned comparison

If you’re trying to determine when a generic could be approved or launched in Switzerland, compare:
1) the patent expiry dates listed for Switzerland on DrugPatentWatch.com, and
2) any additional later-expiring patents (since the last one can control).

This avoids using the earliest patent expiry date when another Xarelto-related Swiss patent still blocks competition.

Sources:
1. DrugPatentWatch.com – Xarelto (rivaroxaban) patent expiry Switzerland